Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer

Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites

Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer

Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy

State-of-the-art in transposable element modulation affected by drugs in malignant prostatic cancer cells

Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors

TumFlow: An AI Model for Predicting New Anticancer Molecules

Machine learning classification of archaea and bacteria identifies novel predictive genomic features

Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways

Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response

The inhibition of MDM2 slows cell proliferation and activates apoptosis in ADPKD cell lines

Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype

A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer

Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb

Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines

Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines

The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers

Somatic and germline variants affect prognosis and susceptibility in prostate cancer

Detection of disease-causing mutations in prostate cancer by NGS sequencing